112 related articles for article (PubMed ID: 18063399)
1. Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease.
Grönke L; Beeh KM; Cameron R; Kornmann O; Beier J; Shaw M; Holz O; Buhl R; Magnussen H; Jörres RA
Pulm Pharmacol Ther; 2008; 21(2):409-17. PubMed ID: 18063399
[TBL] [Abstract][Full Text] [Related]
2. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
3. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
5. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.
Grootendorst DC; Gauw SA; Verhoosel RM; Sterk PJ; Hospers JJ; Bredenbröker D; Bethke TD; Hiemstra PS; Rabe KF
Thorax; 2007 Dec; 62(12):1081-7. PubMed ID: 17573446
[TBL] [Abstract][Full Text] [Related]
6. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
7. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
[TBL] [Abstract][Full Text] [Related]
8. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.
Sapey E; Bayley D; Ahmad A; Newbold P; Snell N; Stockley RA
Thorax; 2008 Jun; 63(6):493-9. PubMed ID: 18057097
[TBL] [Abstract][Full Text] [Related]
9. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.
Lapperre TS; Snoeck-Stroband JB; Gosman MM; Stolk J; Sont JK; Jansen DF; Kerstjens HA; Postma DS; Sterk PJ;
Am J Respir Crit Care Med; 2004 Sep; 170(5):499-504. PubMed ID: 15172889
[TBL] [Abstract][Full Text] [Related]
12. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
[TBL] [Abstract][Full Text] [Related]
13. Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: a randomised controlled trial.
Dahl R; Titlestad I; Lindqvist A; Wielders P; Wray H; Wang M; Samuelsson V; Mo J; Holt A
Pulm Pharmacol Ther; 2012 Apr; 25(2):169-77. PubMed ID: 22306193
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-dose theophylline on airway inflammation in COPD.
Kobayashi M; Nasuhara Y; Betsuyaku T; Shibuya E; Tanino Y; Tanino M; Takamura K; Nagai K; Hosokawa T; Nishimura M
Respirology; 2004 Jun; 9(2):249-54. PubMed ID: 15182277
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
Kanehara M; Yokoyama A; Tomoda Y; Shiota N; Iwamoto H; Ishikawa N; Taooka Y; Haruta Y; Hattori N; Kohno N
Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
[TBL] [Abstract][Full Text] [Related]
16. [Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline].
Ding YL; Yao WZ; Liu Z; Wang YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):441-4. PubMed ID: 16115390
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial.
Neighbour H; Boulet LP; Lemiere C; Sehmi R; Leigh R; Sousa AR; Martin J; Dallow N; Gilbert J; Allen A; Hall D; Nair P
Clin Exp Allergy; 2014 Apr; 44(4):508-16. PubMed ID: 24286456
[TBL] [Abstract][Full Text] [Related]
18. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.
Holz O; Khalilieh S; Ludwig-Sengpiel A; Watz H; Stryszak P; Soni P; Tsai M; Sadeh J; Magnussen H
Eur Respir J; 2010 Mar; 35(3):564-70. PubMed ID: 19643947
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
20. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
